跳至主要内容
临床试验/NCT01384656
NCT01384656已完成4 期

Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome

Yonsei University1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2011年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
66
试验地点
1
主要终点
CK-MB(creatinine kinase-MB) mass

研究概览

简要总结

Patients undergoing multivessel off-pump coronary bypass surgery (OPCAB) inevitably experience cumulative ischemia-reperfusion injury at myocardium. Glucose-insulin-potassium (GIK) is a potentially useful adjunct to myocardial protection. This study was designed to evaluate the effects of GIK infusion on myocardium in patients undergoing OPCAB. Patients undergoing OPCAB with acute coronary syndrome are randomly assigned to GIK or Control group. The trial is double-blind and conducted at a single center.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing isolated OPCAB.
  • Age: 20~75.

排除标准

  • Emergency operation.
  • Patients with MR ≥
  • Patients with IDDM.
  • Patients with random sugar ≥ 250 mg/dL.
  • Patients with serum creatinine ≥ 2.0 mg/dL.
  • Patients with acute myocardial infarction within 1 week of surgery

研究组 & 干预措施

GIK group

Experimental

干预措施: GIK solution (Drug)

Control group

Placebo Comparator

干预措施: GIK solution (Drug)

结局指标

主要结局

CK-MB(creatinine kinase-MB) mass

时间窗: 12 hours after the surgery

Comparison of cardiac enzyme elevation after surgery between GIK and Control group.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验